Randomized Parallel Controlled Study of Wenfeizhiluidan in the Treatment of Allergic Rhinitis with Deficiency of Lung Qi and Cold

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v4i2.1242

Jipeng Wang1, Xiong Zhang2

1. Shaanxi University of Chinese Medicine, Xianyang 712099, Shaanxi, China
2. The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712099, Shaanxi, China

Abstract

Objective — To study a randomized parallel control study of allergic rhinitis. Methods — 106 patients with lung Qi deficiency and cold allergic rhinitis treated in the hospital from March 2022 to March 2023 were selected as the study objects. The patients were divided into observation group and control group according to the random parity method. 53 patients in each group took desloratadine, and the observation group took warm lung flow stop for treatment. The clinical effect, the level of inflammatory factors before and after treatment, and the immune function were compared between the two groups. Results — For the observed and control groups, 96.23% was higher than 75.47% (P<0.05). After treatment, the TNSS and RQLQ scores between the observation and control groups were lower (P<0.05). IL-33, TNF-α, and IFN-γ levels were lower in the observed and control groups (P<0.05). IgE, EOS and EOT were higher in observation and control groups (P<0.05). Conclusion — Patients with lung Qi deficiency cold allergic rhinitis after taking warm lung flow Dan treatment, the clinical effect is remarkable, can effectively improve the clinical symptoms of patients, reduce their inflammatory response, improve the immune function of patients, with high clinical application value.

Keywords

pulmonary Qi deficiency cold type, allergic rhinitis, warm lung flow Dan, clinical effect

References

[1] Naixia Yan. Effect of warm lung flow Dan combined with YupingingPowder in treating allergic rhinitis [J]. Urban and Rural Enterprise Health in China, 2021,36 (4): 159-160.
[2] Gemin Xiao, Wenhai Guo, Min Dai, et al. Study on the efficacy and regulation of Treg cell-related factors between Xiaoqinglong decoction and Xiaobubuhu decoction in treating patients with lung qi deficiency and cold allergic rhinitis [J]. The Journal of Practical Medicine,2021,37(17):2287-2291.
[3] Yanni Li,Dongdong Liu ,Dong Hou , et al. Clinical observation of the cold syndrome of lung qi deficiency in children with allergic rhinitis [J]. The Chinese folk therapy,2023,31(1):65-68.
[4] Jianru Ye, Wenyong Chen . Clinical study on the treatment of lung qi deficiency and cold allergic rhinitis [J]. Journal of Guangzhou University of Traditional Chinese Medicine,2022,39(2):312-317.
[5] Naixia Yan.Effect of warm lung flow Dan combined with YupingingPowder in the treatment of allergic rhinitis [J]. Urban and rural enterprise health in China,2021,36(04):159-160.
[6] Lei Chen. Several clinical issues that should be addressed in the treatment of allergic rhinitis [J]. The Chinese Journal of Otolaryngology, Head and Neck Surgery,2020,55(5):437-439.
[7] Huabin Li, Xiangdong Wang, Hongtian Wang, et al. Oral H1 antihistamines for allergic rhinitis 2018 Guangzhou Consensus [J]. Chinese Journal of Eye, Ear and Otolaryngology,2018,18(3):149-156.
[8] Wenming Chen, Jingbo Li, Huimin Wang, Junjie Wang, Chai Feng.The treatment and mechanism of lung qi deficiency and cold allergic rhinitis [J]. Chinese Journal of Experimental Formulology,2019,25(22):55-59.
[9] Yingchun Li, Jian Huang.Correlation study of TCM syndrome with serum 25-OH and vitamin D_3 and interleukin in allergic rhinitis [J]. Hebei Traditional Chinese Medicine, 2020,42 (08): 1151-1154 + 1160.
[10] Xiaodong Liu , Yanping Zhang. Analysis of the clinical effect of treating pediatric allergic rhinitis (pulmonary qi deficiency and cold type) based on external treatment and internal administration of traditional Chinese medicine [J]. Qiannan Ethnic Medical Special Journal,2016,29(03):173-175.

Copyright © 2023 Jipeng Wang, Xiong Zhang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License